Augusto A Litonjua1. 1. Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Golisano Children's Hospital at Strong, University of Rochester Medical Center, Rochester, New York, USA.
Abstract
PURPOSE OF REVIEW: To review the literature of the past 18 months (April 2017 through September, 2018) relating to vitamin D and childhood asthma. RECENT FINDINGS: A combined analysis of two clinical trials of maternal vitamin D supplementation trials showed a significant protective effect of vitamin D supplementation trials in the primary prevention of asthma and recurrent wheeze up to age 3 years. Secondary analyses from these trials have also suggested that initial maternal vitamin D status could affect the response to supplementation during pregnancy, with the biggest protective effect in children born to mothers with initial 25hydroxyvitamin D (25OHD) levels of at least 30 ng/ml. A postnatal, 6-month vitamin D supplementation trial in black, premature babies showed a 34% decreased risk of recurrent wheezing at 1 year among the infants who received supplementation. An individual patient data meta-analysis of published clinical trials concluded that vitamin D supplementation decreased the risk of asthma exacerbations in those with 25OHD levels less than 10 ng/ml. Results of observational analyses on primary prevention of asthma and in prevention of exacerbations remain mixed, with the bulk of the evidence suggesting that there is a protective effect of higher vitamin D levels. SUMMARY: Evidence continues to accumulate that vitamin D supplementation helps to prevent the development of asthma and recurrent wheeze in early life, and may also help in the management of asthma. The level(s) of circulating vitamin D that maximizes these effects remains to be identified.
PURPOSE OF REVIEW: To review the literature of the past 18 months (April 2017 through September, 2018) relating to vitamin D and childhood asthma. RECENT FINDINGS: A combined analysis of two clinical trials of maternal vitamin D supplementation trials showed a significant protective effect of vitamin D supplementation trials in the primary prevention of asthma and recurrent wheeze up to age 3 years. Secondary analyses from these trials have also suggested that initial maternal vitamin D status could affect the response to supplementation during pregnancy, with the biggest protective effect in children born to mothers with initial 25hydroxyvitamin D (25OHD) levels of at least 30 ng/ml. A postnatal, 6-month vitamin D supplementation trial in black, premature babies showed a 34% decreased risk of recurrent wheezing at 1 year among the infants who received supplementation. An individual patient data meta-analysis of published clinical trials concluded that vitamin D supplementation decreased the risk of asthma exacerbations in those with 25OHD levels less than 10 ng/ml. Results of observational analyses on primary prevention of asthma and in prevention of exacerbations remain mixed, with the bulk of the evidence suggesting that there is a protective effect of higher vitamin D levels. SUMMARY: Evidence continues to accumulate that vitamin D supplementation helps to prevent the development of asthma and recurrent wheeze in early life, and may also help in the management of asthma. The level(s) of circulating vitamin D that maximizes these effects remains to be identified.
Authors: John M Brehm; Brooke Schuemann; Anne L Fuhlbrigge; Bruce W Hollis; Robert C Strunk; Robert S Zeiger; Scott T Weiss; Augusto A Litonjua Journal: J Allergy Clin Immunol Date: 2010-06-09 Impact factor: 10.793
Authors: Ilse I M Tromp; Oscar H Franco; Edith H van den Hooven; Annemieke C Heijboer; Vincent W V Jaddoe; Liesbeth Duijts; Johan C de Jongste; Henriëtte A Moll; Jessica C Kiefte-de Jong Journal: Clin Nutr Date: 2016-12-08 Impact factor: 7.324
Authors: John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: Eve Hornsby; Paul E Pfeffer; Nancy Laranjo; William Cruikshank; Marina Tuzova; Augusto A Litonjua; Scott T Weiss; Vincent J Carey; George O'Connor; Catherine Hawrylowicz Journal: J Allergy Clin Immunol Date: 2017-05-26 Impact factor: 10.793
Authors: Emma S Chambers; Alexandra M Nanzer; Paul E Pfeffer; David F Richards; Peter M Timms; Adrian R Martineau; Christopher J Griffiths; Christopher J Corrigan; Catherine M Hawrylowicz Journal: J Allergy Clin Immunol Date: 2015-03-13 Impact factor: 10.793
Authors: Augusto A Litonjua; Vincent J Carey; Nancy Laranjo; Benjamin J Harshfield; Thomas F McElrath; George T O'Connor; Megan Sandel; Ronald E Iverson; Aviva Lee-Paritz; Robert C Strunk; Leonard B Bacharier; George A Macones; Robert S Zeiger; Michael Schatz; Bruce W Hollis; Eve Hornsby; Catherine Hawrylowicz; Ann Chen Wu; Scott T Weiss Journal: JAMA Date: 2016-01-26 Impact factor: 56.272
Authors: Helene M Wolsk; Bo L Chawes; Augusto A Litonjua; Bruce W Hollis; Johannes Waage; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard; Scott T Weiss Journal: PLoS One Date: 2017-10-27 Impact factor: 3.240
Authors: Andressa Daronco Cereta; Vinícius Rosa Oliveira; Ivan Peres Costa; Letícia Lopes Guimarães; João Pedro Ribeiro Afonso; Adriano Luís Fonseca; Alan Robson Trigueiro de Sousa; Guilherme Augusto Moreira Silva; Diego A C P G Mello; Luis Vicente Franco de Oliveira; Renata Kelly da Palma Journal: Front Med (Lausanne) Date: 2021-06-16
Authors: Kelsea M Drall; Catherine J Field; Andrea M Haqq; Russell J de Souza; Hein M Tun; Nadia P Morales-Lizcano; Theodore B Konya; David S Guttman; Meghan B Azad; Allan B Becker; Diana L Lefebvre; Piush J Mandhane; Theo J Moraes; Malcolm R Sears; Stuart E Turvey; Padmaja Subbarao; James A Scott; Anita L Kozyrskyj Journal: Gut Microbes Date: 2020-11-09